Robert Holt to Fusobacterium nucleatum
This is a "connection" page, showing publications Robert Holt has written about Fusobacterium nucleatum.
Connection Strength
2.401
-
Despins CA, Brown SD, Robinson AV, Mungall AJ, Allen-Vercoe E, Holt RA. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum. mBio. 2021 10 26; 12(5):e0206221.
Score: 0.811
-
Holt RA, Cochrane K. Tumor Potentiating Mechanisms of Fusobacterium nucleatum, A?Multifaceted Microbe. Gastroenterology. 2017 03; 152(4):694-696.
Score: 0.584
-
Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012 Feb; 22(2):299-306.
Score: 0.405
-
Holt RA. Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes. Cell Host Microbe. 2023 01 11; 31(1):141-145.
Score: 0.220
-
Rye MS, Garrett KL, Holt RA, Platell CF, McCoy MJ. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. PLoS One. 2022; 17(1):e0262416.
Score: 0.205
-
Cochrane K, Robinson AV, Holt RA, Allen-Vercoe E. A survey of Fusobacterium nucleatum genes modulated by host cell infection. Microb Genom. 2020 02; 6(2).
Score: 0.177